Skip to main content
ARS Home » Southeast Area » Stoneville, Mississippi » Crop Genetics Research » Research » Publications at this Location » Publication #384706
Research Project: Evaluation and Development of Improved Soybean Germplasm, Curation of USDA Accessions and Regional Evaluations of New Genotypes

Location: Crop Genetics Research

Title: ‘ShowMeSoy 4301’: High yielding soybean with multiple disease resistance and elevated oil content

Author
item CHEN, PENGYIN - University Of Missouri System
item SHANNON, GROVER - University Of Missouri System
item SCABOO, ANDREW - University Of Missouri System
item CRISEL, MELISSA - University Of Missouri System
item SMOTHERS, SCOTTY - University Of Missouri System
item CLUBB, MICHAEL - University Of Missouri System
item SELVES, STEWART - University Of Missouri System
item VIEIRA, CAIO - University Of Missouri System
item ALI, LIAKAT - University Of Missouri System
item LEE, DONGHO - University Of Missouri System
item NGUYEN, HENRY - University Of Missouri System
item LI, ZENGLU - University Of Georgia
item MITCHUM, MELISSA - University Of Georgia
item BOND, JASON - Southern Illinois University
item MEINHARD, CLINTON - University Of Missouri
item USOVSKY, MARIOLA - University Of Missouri System
item Li, Shuxian
item Mengistu, Alemu
item ZHANG, BO - Virginia Tech
item MOZZONI, LEANDRO - University Of Arkansas
item ROBBINS, ROBERT - University Of Arkansas

Submitted to: Journal of Plant Registrations
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 12/7/2021
Publication Date: 5/11/2022
Citation: Chen, P., Shannon, G., Scaboo, A.M., Crisel, M., Smothers, S.L., Clubb, M.W., Selves, S.W., Vieira, C., Ali, L.M., Lee, D., Nguyen, H.T., Li, Z., Mitchum, M.G., Bond, J.P., Meinhard, C.G., Usovsky, M., Li, S., Mengistu, A., Zhang, B., Mozzoni, L.A., Robbins, R.T. 2022. ‘ShowMeSoy 4301’: High yielding soybean with multiple disease resistance and elevated oil content. Journal of Plant Registrations. 16:276-286. https://doi.org/10.1002/plr2.20207.
DOI: https://doi.org/10.1002/plr2.20207

Interpretive Summary: Soybean is one of the most economically important oilseed crops in the world. However, diseases can significantly reduce soybean yield. There has also been an increasing global demand of soybean oil for food and biodiesel industries. ShowMeSoy 4301 is a conventional cultivar. It originated from the cross ‘S08-17361’ x ‘S05-11482’ designed to develop new high-yielding soybean with desirable seed composition and resistance to multiple diseases. ShowMeSoy 4301 was tested from 2014 to 2019 in a total of 150 geographically diverse environments across 13 states including Alabama, Arkansas, Illinois, Indiana, Kansas, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Tennessee, Texas, and Virginia. It showed high-yielding potential, high oil content, and broad adaptability with a comprehensive disease resistance package. ShowMeSoy 4301 would serve as a good soybean variety choice for producers in a wide geographic region.

Technical Abstract: ShowMeSoy 4301 is a conventional early maturity group (MG) IV soybean [Glycine max (L.) Merr.] cultivar released by the University of Missouri – Fisher Delta Research Center soybean breeding program in 2019. It originated from the cross ‘S08-17361’ x ‘S05-11482’ designed to develop new high-yielding germplasm with multiple disease resistance and desirable seed composition. ShowMeSoy 4301 is resistant to charcoal rot, frogeye leaf spot, stem canker, sudden death syndrome, southern root-knot nematode, and moderately resistant to soybean cyst nematode races 1 (H.G Type 2.5.7) and 2 (H.G Type 1.2.5.7), and tolerant to salt stress. Seeds of ShowMeSoy 4301 have 402.4 g kg-1 of protein and 234.9 g kg-1 of oil on a dry weight basis, and 47.8% of meal protein on a 13% moisture basis. ShowMeSoy 4301 was tested from 2014 to 2019 in a total of 150 geographically diverse environments across 13 states including Alabama, Arkansas, Illinois, Indiana, Kansas, Kentucky, Louisiana, Missouri, Mississippi, Ohio, Tennessee, Texas, and Virginia. It showed high-yielding potential and broad adaptability during the evaluation period. Being an early IV conventional line with a comprehensive disease package, ShowMeSoy 4301 would serve as a good variety choice in a wide geographic region.